default author photo

Greta Alì

University of Pisa

Lungarno Pacinotti, 43

Pisa PI, 56126

Italy

SCHOLARLY PAPERS

2

DOWNLOADS

104

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database

Number of pages: 24 Posted: 15 May 2025
“Vito Fazzi” Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, Università degli Studi di Udine - Azienda Sanitaria Universitaria Integrata di Udine, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Pederzoli Hospital-Peschiera del Garda, University of Pavia, University Hospital of Parma, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, University of Pisa, University Hospital Careggi, affiliation not provided to SSRN, Cardinal Massaia Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, Università degli Studi di Genova, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, affiliation not provided to SSRN, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 65 (916,100)

Abstract:

Loading...

alectinib, ALK, Non-small-cell lung cancer, ALK TKIs, Lorlatinib

2.

Braf-Mutant Metastatic Non–Small-Cell Lung Cancer: Real World Data from the Italian Biomarker Atlas Database

Number of pages: 25 Posted: 12 Jun 2025
Ospedale Giovanni Paolo II, affiliation not provided to SSRN, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, affiliation not provided to SSRN, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Careggi University Hospital of Florence - Clinical Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), “Vito Fazzi” Hospital, University of Verona - Hospital Trust, Cardinal Massaia Hospital, Pederzoli Hospital-Peschiera del Garda, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Pisa, ASST Papa Giovanni XXIII, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, affiliation not provided to SSRN, Università degli Studi di Genova, University of Florence, affiliation not provided to SSRN, University of Verona, affiliation not provided to SSRN, University of Pavia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, University of Turin and affiliation not provided to SSRN
Downloads 39 (1,196,171)

Abstract:

Loading...

BRAF mutations, dabrafenib, trametinib, immunotherapy, BRAF V600E, NSCLC, real-world evidence.